Does EZETIMIBE Cause Rhabdomyolysis? 415 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 415 reports of Rhabdomyolysis have been filed in association with EZETIMIBE (Ezetimibe). This represents 3.2% of all adverse event reports for EZETIMIBE.
415
Reports of Rhabdomyolysis with EZETIMIBE
3.2%
of all EZETIMIBE reports
14
Deaths
279
Hospitalizations
How Dangerous Is Rhabdomyolysis From EZETIMIBE?
Of the 415 reports, 14 (3.4%) resulted in death, 279 (67.2%) required hospitalization, and 85 (20.5%) were considered life-threatening.
Is Rhabdomyolysis Listed in the Official Label?
Yes, Rhabdomyolysis is listed as a known adverse reaction in the official FDA drug label for EZETIMIBE.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Rhabdomyolysis?
ATORVASTATIN (3,286)
ROSUVASTATIN (2,173)
SIMVASTATIN (1,616)
LEVETIRACETAM (1,183)
QUETIAPINE (971)
OLANZAPINE (647)
ACETAMINOPHEN (630)
METFORMIN (603)
RISPERIDONE (527)
ARIPIPRAZOLE (516)
Which EZETIMIBE Alternatives Have Lower Rhabdomyolysis Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI